Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

BACKGROUND: We present our experience of therapeutic vaccination using dendritic cells (DC) pulsed with autologous tumor antigens in patients with advanced melanoma. METHODS: Twenty-one pretreated advanced melanoma patients were vaccinated with autologous DC pulsed with 100 μg/ml of autologous-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridolfi, Ruggero, Petrini, Massimiliano, Fiammenghi, Laura, Stefanelli, Monica, Ridolfi, Laura, Ballardini, Michela, Migliori, Giuseppe, Riccobon, Angela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1562447/
https://www.ncbi.nlm.nih.gov/pubmed/16914047
http://dx.doi.org/10.1186/1479-5876-4-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1562447/
https://www.ncbi.nlm.nih.gov/pubmed/16914047
http://dx.doi.org/10.1186/1479-5876-4-36

Ejemplares similares